Skip to main content

Want a detailed portfolio tracker?

Performance analysis of 60 Degrees Pharmaceuticals (SXTP)

Annual Return

Over the past 3 years, SXTP has had an average annual return of -86.91%, underperforming the benchmark SPY, which returned +19.31% annual.

Since Jul 12, 2023, SXTP has had an average annual return of -88.89%, underperforming the benchmark SPY, which returned +19.80% annual.

2026202520242023
-27.78%-92.17%-89.44%-78.21%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+105.56%-24.32%-42.86%-12.50%-7.14%+23.08%-18.75%-27.78%
2025-43.91%-50.39%+3.12%+43.94%-3.16%-8.70%-42.86%+4.17%+6%-9.43%-20.83%-52.63%-92.17%
2024-72.51%-3.51%-3.46%-12.01%+27.09%-13.46%-41.67%-24.13%-6.69%-38.57%+37.96%+21.69%-89.44%
2023-52.14%-37.51%-47.14%-22.58%+8.25%+64.45%-78.21%

Drawdown analysis of 60 Degrees Pharmaceuticals (SXTP)

The maximum drawdown for the SXTP was -99.88%, occurring on May 15, 2026. This drawdown has not yet recovered.

The current SXTP drawdown is -99.87%.

Since Jul 12, 2023 SXTP has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.88%Jul 12, 2023714May 15, 2026OngoingOngoingOngoing